search
Tracel
Trends
- 1Glycosylated RNAs found shaping cell-to-cell communication▼Glycosylated RNAs travel with extracellular vesicles and shape intercellular communication
Researchers report that certain RNA molecules carry sugar modifications, or glycosylation, and travel between cells inside extracellular vesicles. The study suggests these glycosylated RNAs play a functional role in intercellular communication, potentially influencing how cells signal to one another. The findings open new questions about how RNA chemistry shapes biology beyond previously known modifications.
- 2Burn 0.22.0 released with faster builds and autotuning●Burn 0.22.0: Faster Builds, Easier Extensions, and Smarter Autotuning https://tracel.ai/blog/release-0.22.0/ # Rust # Pr
The Burn deep learning framework, written in Rust, has released version 0.22.0. According to the announcement, the update brings faster compile and build times, an easier API for writing extensions, and improved autotuning that selects better settings for running models on different hardware. Developers following the Rust AI ecosystem are sharing the release notes.
- 3New Review Maps Subtypes and Functions of Large Extracellular Vesicles▼Towards a systematic understanding of the diverse subtypes, biogenesis and functions of large extracellular vesicles
Researchers have published a review in Nature calling for a systematic framework to classify large extracellular vesicles, the membrane-bound particles released by cells. The paper outlines the diverse subtypes of these vesicles, how they form, and their roles in cell communication, aiming to bring order to a fast-growing but inconsistent field of study in cell biology.
- 4Everest Biolabs Wins $2.1 Million NIH Grant for Vesicle Biomarker Tech▼Everest Biolabs Awarded $2.1 Million NIH Grant For Extracellular Vesicle Biomarker Technology
Everest Biolabs has been awarded a $2.1 million grant from the US National Institutes of Health to advance its extracellular vesicle biomarker technology. The funding will support development of the company's diagnostic platform, which uses vesicles in bodily fluids as biomarkers for disease detection. The grant highlights continued NIH investment in early-stage biotech working on next-generation diagnostics.